Scale Venture Management II, LLC

CIK 1367512 · last filed 2007-11-21

Scale Venture Management II, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider sold $3.0K of OREX on Nov 21, 2007. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. The firm reports its address in Foster City, CA. 16 SEC filings were submitted jointly with Scale Venture Partners II, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

5

Lifetime Open-Market Net

-$1.86M

Filer Profile

Reported Address

950 TOWER LANE, SUITE 700
FOSTER CITY, CA 94404

Phone

(650) 378-6050

State of Incorporation

Formerly Known As

BA Venture Partners VII, LLC (2006–2006)

Related Filers

Scale Venture Partners II, LP — 16 joint filings, latest 2011-09-22

KATE MITCHELL — 5 joint filings, latest 2011-09-22

Rory O'Driscoll — 5 joint filings, latest 2011-09-22

Sharon L Wienbar — 5 joint filings, latest 2011-09-22

Omniture, Inc. — 4 joint filings, latest 2009-02-10

Mark J Brooks — 2 joint filings, latest 2010-11-29

BANK OF AMERICA VENTURES — same reported address

Scale Venture Partners III, L.P. — same reported address

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Orexigen Therapeutics, Inc. (OREX) Delisted	10%+ Owner	271,744	—	—	-$1.86M	5	2007-11-21

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2007-11-21	Orexigen Therapeutics, Inc. (OREX) Delisted	Sell (S)	−200	-$3.0K	EDGAR
2007-11-19	Orexigen Therapeutics, Inc. (OREX) Delisted	Sell (S)	−60,838	-$953.0K	EDGAR
2007-11-16	Orexigen Therapeutics, Inc. (OREX) Delisted	Sell (S)	−28,412	-$442.8K	EDGAR
2007-11-16	Orexigen Therapeutics, Inc. (OREX) Delisted	Sell (S)	−29,626	-$460.3K	EDGAR
2007-05-02	Orexigen Therapeutics, Inc. (OREX) Delisted	Conv (C)	+5,594,848	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.